NEYPPC Médicaments sous licence Prestation de services de gros pharmaceutiques 26

This tender for pharmaceutical wholesale services is generally well-structured with a substantial estimated value and clear basic information. However, it lacks detailed documentation and specific evaluation criteria, impacting its overall accessibility and transparency.

The tender adheres to standard open procedure requirements and includes a valid CPV code. Deadlines appear reasonable given the scope. No disputes are reported. The procedure is clearly defined as 'Open procedure'.

The description of the service is clear, outlining the replacement of an existing contract for licensed wholesaler services across specific regions. Mandatory exclusion grounds, eligibility, technical, financial, and submission requirements are listed, indicating a structured approach to defining needs.

Key information such as title, reference, organization, estimated value, contract duration, and start date are present. However, the crucial aspect of tender documents is severely lacking, with 'Documents with content/summaries: 0', significantly hindering completeness.

The tender is open, and the estimated value is disclosed. The criteria for evaluation are not specified, which could be a concern for fairness. However, the absence of specific company tailoring and the open nature of the procedure suggest a generally fair approach.

The contract start date and duration are specified. Financing information is not explicitly detailed. The absence of explicit mention of e-submission and the lack of document URLs limit the practicality for potential bidders.

Key fields like title, reference, organization, value, and dates are populated logically. There are no reported suspensions or disputes, and the timeline appears consistent.

There is no explicit mention of green procurement, social aspects, or innovation within the provided tender information. The tender is not indicated as EU funded.